Items where Author is "Hodgson, David"
Number of items: 9.
2022
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust. (2022)
Colton, Hayley; Hodgson, David; Hornsby, Hailey; Brown, Rebecca; Mckenzie, Joanne; Bradley, Kirsty L; James, Cameron; Lindsey, Benjamin B; Birch, Sarah; Marsh, Louise; Wood, Steven; Bayley, Martin; Dickson, Gary; James, David C; Nicklin, Martin J; Sayers, Jon R; Zafred, Domen; Rowland-Jones, Sarah L; Kudesia, Goura; Kucharski, Adam; CMMID COVID-19 Working Group; Darton, Thomas C; de Silva, Thushan I; Collini, Paul J
Determinants of RSV epidemiology following suppression through pandemic contact restrictions. (2022)
Koltai, Mihaly; Krauer, Fabienne; Hodgson, David; van Leeuwen, Edwin; Treskova-Schwarzbach, Marina; Jit, Mark; Flasche, Stefan
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study. (2022)
Li, Xiao; Hodgson, David; Flaig, Julien; Kieffer, Alexia; Herring, William L; Beyhaghi, Hadi; Willem, Lander; Jit, Mark; Bilcke, Joke; Beutels, Philippe; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Invest
picture_as_pdf
2021
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. (2021)
Hodgson, David; Flasche, Stefan; Jit, Mark; Kucharski, Adam J; CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID)
Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study. (2021)
Li, You; Hodgson, David; Wang, Xin; Atkins, Katherine E; Feikin, Daniel R; Nair, Harish
2019
Estimates for quality of life loss due to Respiratory Syncytial Virus. (2019)
Hodgson, David; Atkins, Katherine E; Baguelin, Marc; Panovska-Griffiths, Jasmina; Thorrington, Dominic; van Hoek, Albert Jan; Zhao, Hongxin; Fragaszy, Ellen; Hayward, Andrew C; Pebody, Richard